Aftab Khan, MD
Hospitalist · Birmingham, ALNPI 1811922099
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,254, 7.9 times the $160 reported in 2019. Among hospitalist clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $32.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$964
- Vanda Pharmaceuticals Inc.$508
- Johnson & Johnson$492
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$364
- Phathom Pharmaceuticals, Inc.$317
- Merz Pharmaceuticals, LLC$298
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 9 | $964 |
| Vanda Pharmaceuticals Inc. | 23 | $508 |
| Johnson & Johnson | 17 | $492 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $364 |
| Phathom Pharmaceuticals, Inc. | 3 | $317 |
| Merz Pharmaceuticals, LLC | 10 | $298 |
| Otsuka America Pharmaceutical, Inc. | 12 | $192 |
| AbbVie(2 entities) | 5 | $186 |
| CSL Behring | 5 | $160 |
| Amgen | 2 | $146 |
| Lilly USA, LLC | 2 | $141 |
| Jazz Pharmaceuticals Inc. | 7 | $139 |
| Melinta Therapeutics, LLC | 1 | $125 |
| Boehringer Ingelheim | 1 | $109 |
| Esperion Therapeutics, Inc. | 1 | $106 |
| UCB, Inc. | 3 | $91 |
| Idorsia Pharmaceuticals US Inc | 1 | $85 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Pfizer | 3 | $79 |
| Teva Pharmaceuticals USA, Inc. | 5 | $71 |
| Adlon Therapeutics L.p. | 3 | $60 |
| Tris Pharma Inc | 3 | $55 |
| Lundbeck LLC | 3 | $55 |
| AstraZeneca | 2 | $53 |
| Alkermes, Inc. | 3 | $49 |
| Eisai Inc. | 3 | $45 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $41 |
| Merck | 2 | $33 |
| Sunovion Pharmaceuticals Inc. | 3 | $31 |
| Avanir Pharmaceuticals, Inc. | 2 | $28 |
| Ironshore Pharmaceuticals Inc. | 1 | $25 |
| Neos Therapeutics, LP | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,196 in reported general payments places this provider in the 95th percentile of 265 hospitalist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 24 | $5,089 |
| Hydroxychloroquine Sulfate | 11 | $482 |
| Bupropion XlBupropion Hcl | 25 | $353 |
| Paroxetine Hcl | 17 | $232 |
| Trazodone Hcl | 24 | $177 |
| Alprazolam | 40 | $148 |
| Escitalopram Oxalate | 24 | $115 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $76 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $65 |
| Donepezil Hcl | 11 | $65 |
| Oxycodone Hcl | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Birmingham
- Mark CromerBirmingham$4K
- Matthew BurdenBirmingham$4K
- Faheem ShaikhBirmingham$3K
- Sandeep VirkBirmingham$3K
- Laura KukucBirmingham$2K
- Siddharth BansalBirmingham$2K
- Peter HwangBirmingham$1K
- Jorge PinoBirmingham$989
- George TisdaleBirmingham$909
- Brandon BringuelBirmingham$875
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.